Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade.

Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade. Clin Cancer Res. 2019 02 01; 25(3):989-999.

View in: PubMed

subject areas

Animals
Antibodies, Blocking
Antineoplastic Agents, Immunological
B7-H1 Antigen
Carcinoma, Non-Small-Cell Lung
Cell Line, Tumor
Female
Humans
Immunoglobulin Fc Fragments
Lung Neoplasms
Macrophages
Male
Mice, Nude
Mice, SCID
Programmed Cell Death 1 Receptor
Receptors, Fc
Tumor Burden
Xenograft Model Antitumor Assays

authors with profiles

Marina Chiara Garassino